Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

UW joins the Alliance for Therapies in Neuroscience to transform the fight against neurological diseases

The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between academia and industry geared to transform the fight against brain diseases and disorders of the central nervous system.

26 Sep 2022

Designing a new treatment to treat migraine effectively

In this interview, we speak to Mudra Kapoor, Vice President of Global Medical Affairs for Neuroscience at AbbVie, about atogepant, their new treatment option for migraine.

From AbbVie 26 Sep 2022

Blueberries, a tasty intervention against age-related cognitive decline

In a recent study published in the Nutritional Neuroscience journal, researchers assessed the impact of consumption of wild blueberries on the speed of processing in mild cognitive decline.

25 Sep 2022

Study identifies a potential non-invasive therapy that could check the progress of Alzheimer's disease

A new study conducted by the scientist of the UMA Inés Moreno, in collaboration with the University of Texas, has identified a potential non-invasive therapy that could check the progress of Alzheimer's disease, "the major form of dementia in the elderly population".

23 Sep 2022

Study shows 72% increase in new diagnoses of type 1 diabetes in young COVID-19 patients

Children who were infected with COVID-19 show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study that analyzed electronic health records of more than 1 million patients ages 18 and younger.

23 Sep 2022

Study reveals the long-term neurologic consequences of COVID-19

If you've had COVID-19, it may still be messing with your brain. Those who have been infected with the virus are at increased risk of developing a range of neurological conditions in the first year after the infection, new research shows.

22 Sep 2022

Salk scientists launch a new Center for Multiomic Human Brain Cell Atlas with $126 million NIH grant

With a five-year, $126 million grant from the National Institutes of Health, a team led by Salk Institute scientists has launched a new Center for Multiomic Human Brain Cell Atlas.

22 Sep 2022

Mount Sinai researchers use unbiased AI-based method to study the causes of cognitive impairment

Mount Sinai researchers have used novel artificial intelligence methods to examine structural and cellular features of human brain tissues to help determine the causes of Alzheimer's disease and other related disorders.

21 Sep 2022

Mutation in newly discovered small protein linked to increase in Alzheimer's disease risk

A mutation in a newly discovered small protein is connected to a significant increase in the risk for Alzheimer's disease, expanding the known gene targets for the disease and presenting a new potential avenue for treatment, according to a new USC study.

21 Sep 2022

Covid still kills, but the demographics of its victims are shifting

As California settles into a third year of pandemic, covid-19 continues to pose a serious threat of death. But the number of people dying — and the demographics of those falling victim — has shifted notably from the first two years.

21 Sep 2022

SARS-CoV-2 generates amyloid in cerebral spinal fluid

In a recent study posted to the bioRxiv* preprint server, an international team of researchers demonstrated amyloid aggregation due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cerebrospinal fluid (CSF).

20 Sep 2022

Discovery could resolve one of the mysteries of Parkinson's disease

Aggregates of the protein alpha-synuclein spread in the brains of people with Parkinson's disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.

20 Sep 2022

NPDPSC at Case Western Reserve University to receive CDC funding for better understanding of prion diseases

The National Prion Disease Pathology Surveillance Center at Case Western Reserve University will receive up to $20 million in funding as part of a grant renewal from the Centers for Disease Control and Prevention (CDC) to better understand how and why prion diseases––degenerative brain conditions found in both humans and animals - develop and spread.

20 Sep 2022

Green tea molecule can break up protein tangles in the brain that cause Alzheimer’s

Scientists at UCLA have used a molecule found in green tea to identify additional molecules that could break up protein tangles in the brain thought to cause Alzheimer's and similar diseases.

20 Sep 2022

Clearing pollution helps clear the fog of aging — and may cut the risk of dementia

During the past decade, a growing body of research has shown that air pollution harms older adults' brains, contributing to cognitive decline and dementia. What hasn't been clear is whether improving air quality would benefit brain health.

20 Sep 2022

Daily multivitamin improves cognitive function in seniors

In a recent study published in the journal Alzheimer's & Dementia, researchers in the United States investigated whether daily administration of a cocoa extract (CE, comprising 500 mg flavanols, including 80 mg epicatechins, 50 mg/day theobromine (50 mg/day), and 15mg/day caffeine) and/or an MVM (multivitamin-mineral) for three years protected cognitive functions among older men and women.

18 Sep 2022

COVID-19 increases risk of developing Alzheimer's by 50-80% in older adults

In a recent study published in the Journal of Alzheimer’s Disease, researchers investigated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections could trigger the development of new-onset Alzheimer’s disease (AD)

18 Sep 2022

RIT scientist receives $1.7 million NIH award to study how cells control the size of organelles

A Rochester Institute of Technology scientist hopes that a better understanding of how living cells maintain the size of their organelles can lead to therapies for neurodegenerative diseases.

16 Sep 2022

Machine learning can help create proteins much more accurately, quickly than previously possible

Over the past two years, machine learning has revolutionized protein structure prediction. Now, three papers in Science describe a similar revolution in protein design.

15 Sep 2022

Study investigates link between plasma miRNAs and cognitive function among cognitively normal men

A new research paper was published on the cover of Aging (listed as "Aging (Albany NY)" by Medline/PubMed and "Aging-US" by Web of Science) Volume 14, Issue 17, entitled, "Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study."

15 Sep 2022

Alzheimer's Disease News and Research

Further Reading

UW joins the Alliance for Therapies in Neuroscience to transform the fight against neurological diseases

Designing a new treatment to treat migraine effectively

Blueberries, a tasty intervention against age-related cognitive decline

Study identifies a potential non-invasive therapy that could check the progress of Alzheimer's disease

Study shows 72% increase in new diagnoses of type 1 diabetes in young COVID-19 patients

Study reveals the long-term neurologic consequences of COVID-19

Salk scientists launch a new Center for Multiomic Human Brain Cell Atlas with $126 million NIH grant

Mount Sinai researchers use unbiased AI-based method to study the causes of cognitive impairment

Mutation in newly discovered small protein linked to increase in Alzheimer's disease risk

Covid still kills, but the demographics of its victims are shifting

SARS-CoV-2 generates amyloid in cerebral spinal fluid

Discovery could resolve one of the mysteries of Parkinson's disease

NPDPSC at Case Western Reserve University to receive CDC funding for better understanding of prion diseases

Green tea molecule can break up protein tangles in the brain that cause Alzheimer’s

Clearing pollution helps clear the fog of aging — and may cut the risk of dementia

Daily multivitamin improves cognitive function in seniors

COVID-19 increases risk of developing Alzheimer's by 50-80% in older adults

RIT scientist receives $1.7 million NIH award to study how cells control the size of organelles

Machine learning can help create proteins much more accurately, quickly than previously possible

Study investigates link between plasma miRNAs and cognitive function among cognitively normal men

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News